vTv Therapeutics Insider Trades
NASDAQ: VTVTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
vTv Therapeutics insider activity
No vTv Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows AKKARAJU SRINIVAS (Director) reporting a transaction in 106,000 shares at $15.27 on Sep 22, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VTVT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VTVT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 22, 2025 | AKKARAJU SRINIVASDirector | Award | 106,000 | $1.62M | Form 4 |
| Sep 3, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIAN & Baker Bros. Advisors (GP) LLCDirector | Award | 46,692 | — | Form 4 |
| Sep 3, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIAN & Baker Bros. Advisors (GP) LLCDirector | Award | 4,308 | — | Form 4 |
| Nov 18, 2024 | SEKHRI PAUL JPres, CEO and Exec Chairperson | Buy | 1,844 | $31.27K | Form 4 |
| Nov 15, 2024 | SEKHRI PAUL JPres, CEO and Exec Chairperson | Buy | 1,778 | $30.01K | Form 4 |
| Nov 15, 2024 | SEKHRI PAUL JPres, CEO and Exec Chairperson | Buy | 1,378 | $22.53K | Form 4 |
| Mar 5, 2024 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIAN & Baker Bros. Advisors (GP) LLCDirector | Disposition | 52,881 | — | Form 4 |
| Mar 5, 2024 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIAN & Baker Bros. Advisors (GP) LLCDirector | Disposition | 4,776 | — | Form 4 |
| Mar 5, 2024 | Samsara BioCapital GP, LLC & Samsara BioCapital, L.P.10% Owner | other | 58,836 | — | Form 4 |
| Mar 5, 2024 | AKKARAJU SRINIVASDirector | Disposition | 58,836 | — | Form 4 |
| Feb 27, 2024 | AKKARAJU SRINIVASDirector | Award | 224,732 | $2.65M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4